Advisory Committee
Business Advisors
Gene Saragnese
Gene Saragnese joined MaxQ Technology Ltd. in January 2016, as its Chairman & Chief Executive Officer. MaxQ is a company founded in deep learning and computer vision. MaxQ delivers patient-specific lifesaving diagnostic information directly to the physician at the patient’s bedside. In early 2020, he moved into the role of Vice Chairman at MaxQ.
Mr. Saragnese also served as the Chairman of the Board of Mirada Medical, a Healthcare SW company and Independent director on the Insightec board. Prior to joining MaxQ, Gene Saragnese served as the Philips Healthcare CEO of Philips Imaging Systems from April 2009 until May 2015.
As the Executive Vice President and CEO of Philips Imaging Systems, he led the company's Imaging Systems business, a $7.5B enterprise, encompassing Advanced Diagnostic Imaging (Computed Tomography, Magnetic Resonance Imaging, and Molecular Imaging); Diagnostic X-Ray; Interventional and Ultrasound. He also directed Integrated Clinical Solutions which took a disease-focused approach to health care, and included the radiation and interventional oncology business. He was responsible for 10,000 employees at sites in the United States, India, the Netherlands, Germany, Israel, China and Brazil.
Before joining Philips, Mr. Saragnese served as GE Healthcare’s Vice President and General Manager of Molecular Resonance Imaging and Computed Tomography. In this capacity, he led a multi-billion-dollar business group, including Computed Tomography, Positron Emission Tomography (PET), Nuclear Imaging, PET Radiopharma, Preclinical Imaging and Image Post Processing. Prior to that, he served as Chief Technology Officer, Vice President of Global Technology for GE Healthcare. In this role, Mr. Saragnese led Global Product Development Engineering and Component Operations around the world, including Corporate Research sites in New York, China, India and Germany. He has also served as General Manager Global Sourcing leading a global $6B procurement operation, General Manager for GE Medical Systems’ Global MRI business and the leader for GE Medical Systems’ Global MRI Engineering organization.
Prior to his career in health care, Mr. Saragnese held management roles with GE, RCA, Martin Marietta and Lockheed Martin in the aerospace industry. He is a graduate of Rutgers College of Engineering in New Jersey.
Michael Harsh, former CTO of GE Healthcare
Michael Harsh is a co-founder and Chief Product Officer of Terapede Systems, a digital X-ray startup that focuses on developing an ultra-high resolution medical flat panel X-ray detector. He co-founded Terapede in 2015. Prior to Terapede, Mr. Harsh had a 36-year career with General Electric (GE). He held numerous positions within GE and served as Vice President and Chief Technology Officer of GE Healthcare, an $18 billion division of GE, where he led its global science and technology organization and research and development teams in diagnostics, healthcare IT and life sciences. In 2004, Mike was named Global Technology Leader – Imaging Technologies at the GE Global Research Center, where he led the research for imaging technologies across the company as well as the research associated with computer visualization and superconducting systems.
Additionally, Mr. Harsh is a member of the boards of directors of, Compute Health (NYSE: CPUH-UN), Endra Life Sciences (NASDAQ: NDRA), Imagion Biosystems (IBX.AX), and EmOpti as well as being a member the Radiological Society of North America ("RSNA"), Research & Education Foundation Board of Trustees. He had previously served as a director for FloDesign Sonics until its acquisition by MilliporeSigma, a division of the Merck Group. He is also a McKinsey Senior Advisor and a consultant in the medical device industry. Mr. Harsh is a graduate of Marquette University, where he earned a bachelor’s
degree in Electrical Engineering. He holds numerous U.S. patents in the field of medical imaging and instrumentation. In 2008, Mr. Harsh was elected to the American Institute for Medical and Biological Engineering College of Fellows for his significant contributions to the medical and biological engineering field.
Allan Wong, Vtech Chairman and Founder
Mr. Wong (Chairman of the Committee) Entrepreneur ，the co-founder, chairman and CEO of VTech Group; chairman of Innovation Technology Committee of Hong Kong, member of Institute of Applied Science and Technology, member of the board of trustees of University of Hong Kong, vice chairman and independent non-executive director of Bank of East Asia, independent non-executive director of China-Hong Kong Photo Products Holdings Ltd. and Hong Kong Li & Fung. Mr. Wong won the Chiang's Science and Technology achievement award in 1999, and ranked 203 on the Forbes list of richest Chinese in 2015. Mr. Wong received a Bachelor degree of Science in electrical engineering, University of Hong Kong, a master degree of Science in Electrical and Computer Engineering, University of Wisconsin, Madison, USA, and an honorary doctor of Science and Technology, Hong Kong University of Technology.
Yulin Wei, former Chairman and President of SinoPharma Holding
MBA, senior economist, licensed pharmacist. From September 1984 to January 1999, he successively served as the salesman， and manager/deputy general manager/executive deputy general manager of pharmaceutical company of development zone of Pharmaceutical Department of Tianjin Pharmaceutical Center of China Pharmaceutical Group; from January 1999 to January 2003, he served as the general manager of Tianjin Company of China Pharmaceutical Group; from January 2003 to March 2017, he successively served as the chief operating officer, executive deputy general manager, President and chairman of Sinopharm Holding Co., Ltd. Since 2017, he has been the CEO of Sinopharm holding Medical Investment Management Co., Ltd. He has been awarded by Tianjin, China Pharmaceutical Group Corporation, the Ministry of Human Resources and Social Security of China, and Shanghai Municipal government successively; won the best business leader award of China in 2012, and was elected as the best CEO of the year; won the most respected chairman of China's listed companies and the leader of international multinational companies in 2016; and elected as an outstanding person in the 40th anniversary of reform and opening up of China's pharmaceutical circulation industry in 2019.
Scientific Advisors
Richard Ehman, Professor of Radiology at Mayo Clinic and former Chair of Radiology Section at NIH
Richard L. Ehman, MD, is Professor of Radiology and Blanche and Richard Erlanger Professor of Medical Research at the Mayo Clinic. His research program is focused on developing advanced imaging technologies. He holds more than 100 US and foreign patents for his inventions, many widely used in medical care. He has served as chair of the Radiology and Nuclear Medicine Study Section of the NIH and on the National Advisory Council of NIBIB. He has been awarded Gold Medals by the International Society for Magnetic Resonance in Medicine, the Society of Advanced Body Imaging, and the Radiological Society of North America. He is a Fellow of the National Academy of Inventors and is an elected member of the National Academy of Medicine. He has served as president of the ISMRM, the Academy of Radiology Research, and the Society for Advanced Body Imaging and the Radiological Society of North America.
CC Chan, member of CAE and former Head of EEE Department of University of Hong Kong
Prof. C. C. Chan holds BSc, MSc, PhD, HonDSc, HonDTech degrees. Honorary Professor and Former Head of the Department of Electrical and Electronic Engineering at the University of Hong Kong; Visiting Professor of MIT, University of Cambridge, etc; Founding President of the World Electric Vehicle Association; Senior Consultant to governments, Strategic Adviser or Independent Director of public companies and industries; Fellow of the Royal Academy of Engineering, U.K., Chinese Academy of Engineering, IEEE, IET and HKIE.
Yuliang Yang, member of CAS and former President of Fudan University
Yuliang Yang was born in Haiyan County, Zhejiang Province in November 1952.
He studied in the Department of chemistry of Fudan University from 1974 to 1977. In 1984, he obtained a Ph.D. degree in Chemistry (polymer chemistry and Physics) from Fudan University by his doctoral dissertation "graph theory of static and dynamic behavior sof polymer chain".
Then (1986-1988), he went to the German Max-Planck Institute of Polymer Research worked as a postdoc. The research topic in that period focused on the development of solid-state NMR research methods for polymeric condensed states.
Since 1993, he has been professor of polymer science, Fudan University. He was elected academician of Chinese Academy of Sciences in 2003. Then (1999-2006) served as vice president of Fudan University, responsible for scientific research and transformation of scientific research results.
Later (2006-2009), he went to Beijing to serve as the director of the office of the degree committee, State Council. After returning to Shanghai (2009-2014), he was appointed as the president of Fudan University.
After abdication from the position of President of Fudan University (2014~), he served as the director of the Institute for Preservation and Conservation of Chinese Ancient Books, Fudan University. Subsequently (2015~), he also served as the director of the science education and Popularization Committee of the Chinese Academy of Sciences.
Patrick Cheng, member of CAS and former President of University of Hong Kong
Prof. Cheng conducted pioneering research work in MOS technology in late 60 to 80 in Canada and HK and the Academician, Chinese Academy of Sciences. He at former President in City University of Hong Kong and former VC at The University of Hong Kong. He is Honorary Professor at University of Electronic Science and Technology of China, City University of Hong Kong, South China U of Science and Technology.
